Halal Pharmaceuticals in Malaysia: A Business Owner’s Guide to Certification Readiness

Introduction

Halal pharmaceutical certification is not only about whether a finished product contains permissible ingredients. For manufacturers, product owners, contract manufacturers, and healthcare product businesses, it is a comprehensive compliance system that integrates Shariah requirements, pharmaceutical regulations, Good Manufacturing Practice, material source verification, facility controls, documentation, audit readiness, and long-term monitoring.

In Malaysia, halal pharmaceuticals sit at the intersection of two important expectations: Halalan and Toyyiban. Halalan refers to permissibility under Shariah requirements, while Toyyiban relates to safety, quality, suitability, and assurance for the intended use. This means a halal pharmaceutical product must not only avoid prohibited or doubtful materials; it must also be produced under a controlled, safe and quality-assured manufacturing system.

For business owners, the key question is not simply, “Can my product be halal certified?” A better question is, “Is my formulation, facility, documentation, and supply chain ready to prove halal integrity during audit?”

Why Halal Pharmaceuticals Require More Than Ingredient Checking

A pharmaceutical product may contain active ingredients, excipients, solvents, capsule shells, coatings, preservatives, stabilisers, flavourings, and processing aids. Each of these materials may have different origins and risk levels. Some may come from plant, mineral, synthetic, microbial, animal, or fermentation-based sources. Others may involve alcohol, enzymes, gelatine, glycerine, stearates, or biological materials.

This is why halal pharmaceutical certification must begin at the formulation and sourcing stage. If a business waits until the product is manufactured, packed, and distributed before checking its halal status, it may discover that certain materials, suppliers, or production processes are unsuitable.

A halal-ready pharmaceutical business should be able to answer several basic questions:

• Where does each material come from?
• Is the source permitted?
• Is there any animal-derived content?
• Is there any alcohol or solvent concern?
• Are supplier certificates valid and recognised?
• Does the manufacturing process prevent contamination?
• Can the company trace materials from supplier to finished product?

These questions show why halal certification is a system, not a one-time label exercise.

The Role of Pharmaceutical Regulation and Halal Certification

Pharmaceutical products in Malaysia are regulated through the relevant health authorities and product registration or notification requirements. Product quality, safety, and efficacy remain essential. Halal certification does not replace pharmaceutical regulatory approval. Instead, it adds another layer of assurance related to Shariah compliance, material permissibility, contamination control, and halal integrity.

This distinction is important for business owners. A product that is registered, notified, or manufactured under GMP is not automatically halal-certified. GMP helps control quality, hygiene, documentation, production, testing, complaints, recalls, and facility standards. However, halal certification requires additional review of ingredient sources, contact materials, non-halal contamination risk, halal facility control, internal halal governance, and certification-specific documentation.

In simple terms:

Pharmaceutical regulation asks: Is the product safe, effective, and quality-controlled?
Halal certification asks: Is the product, its materials, its process, and its handling compliant with halal requirements?

A strong business should prepare for both.

Understanding MS 2424 and Halal Pharmaceutical Requirements

MS 2424:2019 provides the Malaysian Standard reference for halal pharmaceuticals. From a practical business perspective, this standard supports the manufacturing and handling requirements for halal pharmaceutical products. It helps companies understand that halal assurance must cover materials, premises, equipment, personnel, processing, packaging, storage, and distribution.

A halal pharmaceutical product should avoid prohibited ingredients, najis contamination, impermissible animal derivatives, human-derived materials that are not allowed, and hazardous use beyond the prescribed purpose. It should also be manufactured using equipment, contact surfaces, and processes that do not compromise halal status.

For manufacturers, this means halal requirements must be translated into operational procedures. It is not enough to have a general policy. The business needs clear controls for purchasing, receiving, quarantine, sampling, dispensing, production, packaging, finished goods storage, and distribution.

High-Risk Materials Business Owners Should Review

The most common halal certification challenges in pharmaceuticals often stem from materials that are in small quantities but critical to compliance. These may include capsule shells, gelatine, collagen, enzymes, glycerine, stearates, lactose, flavouring agents, colourants, coating agents, emulsifiers, preservatives, alcohol-based solvents, and fermentation-derived substances.

Capsules and softgels deserve special attention because gelatine may come from bovine, porcine, fish, or other sources. If the source is animal-based, the business must verify whether it is acceptable and supported by proper halal evidence. Excipients should also be checked, as they may contain hidden animal-derived or alcohol-related components.

Imported ingredients also require careful document review. A supplier may provide a product specification, but that does not always prove halal suitability. Businesses may need halal certificates, certificates of analysis, certificates of origin, material safety data sheets, technical data sheets, supplier declarations, ingredient breakdowns, and recognised evidence of certification.

Aligning GMP with Halal Assurance

Most pharmaceutical manufacturers are already familiar with GMP systems. This is an advantage because GMP provides a strong foundation for discipline, traceability, and controlled production. However, the company should not assume that GMP documentation alone is sufficient for halal certification.

The better approach is to map existing GMP processes into halal control points. For example, receiving procedures can include halal document verification. Material quarantine can separate approved, pending, and rejected materials. Production records can show which approved materials were used. Cleaning procedures can include measures to prevent halal contamination. Change control can include a halal impact assessment before new suppliers, formulations, or equipment are approved.

This creates what many compliance professionals call a “halal built-in” approach. Instead of preparing halal documents only before audit, halal control becomes part of normal business operations.

Building a Halal Assurance System

A pharmaceutical manufacturer seeking halal certification should establish a proper Halal Assurance System. This normally includes halal policy, halal committee or responsible personnel, material source control, facility control, internal halal audit, training, corrective action, traceability, and management review.

The halal committee should not operate separately from the business. It should involve relevant functions such as quality assurance, regulatory affairs, production, purchasing, warehouse, research and development, and management. This is important because halal risk can arise in formulation, sourcing, supplier changes, production flow, cleaning, storage and distribution.

A practical Halal Assurance System should include:

• A clear halal policy
• Approved material list
• Supplier approval procedure
• Raw Material Masterlist
• Halal risk assessment
• Process flow and facility layout
• Internal halal audit procedure
• Training records
• Corrective action records
• Renewal preparation file

These documents help prove that the company has an active control system rather than a passive filing system.

Audit Readiness for Halal Pharmaceutical Certification

Before applying for halal certification, a business should conduct a readiness review. This review should cover product registration or notification status, formulation risk, supplier documentation, material origin, GMP records, facility suitability, production process, storage control, distribution pathway and staff understanding.

During a halal pharmaceutical audit, auditors may review material files, production records, halal committee records, training evidence, warehouse control, equipment status, supplier certificates, traceability documents and corrective action records. They may also assess whether the actual manufacturing practice matches the submitted documents.

Common causes of delay include incomplete supplier files, expired halal certificates, unclear animal-derived sources, unverified capsule shells, weak change control, generic GMP records without halal mapping, no internal halal audit and poor traceability between raw materials and finished products.

Maintaining Certification After Approval

Halal certification is not complete once the certificate is issued. The business must continue to monitor supplier certificates, material changes, formulation changes, facility changes, production line changes and documentation updates. Any change in ingredient source, supplier, manufacturing site, packaging material or process should be assessed for halal impact.

Renewal preparation should begin early. Waiting until the renewal deadline may expose the company to missing records, expired certificates or unresolved corrective actions. A well-managed halal pharmaceutical business should treat renewal as part of continuous compliance, not an emergency task.

FAQs

1. What is a halal pharmaceutical product?

A halal pharmaceutical product is a medicinal or healthcare product that uses permitted ingredients and is manufactured, handled, stored and distributed in a way that supports halal integrity and product safety.

2. Is product registration the same as halal certification?

No. Product registration or notification relates to pharmaceutical regulatory requirements. Halal certification focuses on Shariah compliance, material sources, contamination control, halal assurance and audit evidence.

3. Does GMP automatically make a product halal?

No. GMP supports quality and safety, but halal certification still requires specific controls over ingredients, animal-derived materials, alcohol risk, facility handling, documentation and halal governance.

4. What are common high-risk pharmaceutical ingredients?

Common high-risk materials include gelatine, capsule shells, collagen, enzymes, glycerine, stearates, lactose, flavourings, colourants, preservatives, coating agents, alcohol-based solvents and animal-derived excipients.

5. Why are capsule shells important in halal certification?

Capsule shells may contain gelatine from animal sources. The source must be verified and supported by halal evidence before the product can be considered suitable for halal certification.

6. What documents should manufacturers prepare?

Manufacturers should prepare product formulation records, raw material master lists, supplier halal certificates, product specifications, certificates of analysis, certificates of origin, technical data sheets, process flows, training records, and internal audit records.

7. What is a Raw Material Master List?

A Raw Material Master List records all materials used in production, including ingredient names, suppliers, source information, halal status, certificate validity, supporting documents, and risk-related remarks.

8. What is meant by “halal built-in”?

“Halal built-in” means halal control is designed into sourcing, formulation, production, cleaning, storage, documentation, and distribution from the beginning, rather than being checked only at the final stage.

9. What can delay halal pharmaceutical certification?

Delays may occur due to incomplete documents, unclear material sources, expired certificates, unverified animal derivatives, weak internal audit, poor traceability, inadequate training or process changes that were not assessed.

10. How should a company maintain certification after approval?

The company should monitor supplier certificates, control material and formulation changes, conduct internal halal audits, update records, train staff, maintain traceability and prepare early for renewal.

Conclusion

Halal pharmaceutical certification requires a structured integration of Shariah compliance, pharmaceutical regulation, GMP, material verification, facility control, documentation, and ongoing monitoring. For business owners, the strongest approach is to build halal assurance into the product lifecycle from the earliest stages of formulation and sourcing. When halal control is integrated with quality assurance, regulatory affairs, production, and supply chain management, the business is better prepared for audit, renewal, and long-term market trust.